An Insight Review on Phytochemistry, Pharmacological Evidences, and Biosynthesis of Key Metabolites of Indian Himalayan Cherry (Prunus cerasoides Don.) with Emphasis on its Safety and Use in Tradtional Phytomedicine

Abstract

AbstractPadmaka (Prunus cerasoides Don.), or wild Himalayan cherry, is a deciduous tree from the Rosaceaae family. The Prunus genus has 400–430 species, including shrubs and trees. It is widely distributed across the Himalayan region of India, China, Myanmar, Nepal, and Thailand. It is used in many classical formulations of various Asian traditional medicinal systems viz., Ayurveda, TCM (traditional Chineese Medicines) and TTM (Traditional Thai Medicines) for treating burning sensations, Blisters, blood disorders, dizziness, bleeding disorders, herps, and skin disorders. The present review covers the research updates on P. cerasoides from 1982 to 2023, accessible on scholars’ platforms and databases. More than 200 phytomolecules have been investigated for their biological potential and the discovery of pharmacophores‐inspired drugs. Padmaka instigated over fifty diverse phytochemicals, viz. flavones, isoflavones, chalcones, terpenoids, glycosides, and sterols. The phytochemical flux of P. cerasoides is dominant with phenylpropanoids, anthocyanins, carotenoids, and terpenoids. Several experimental shreds of evidence emphasized the biological significance of P. cerasoides extracts and their derived phytochemicals. Medicinal significance and its safety in clinical validation have been discussed efficiently. Moreover, the barrier in validated therapeutics is a lack of information on the bioavailability of specialized bioactive, standardization, safety, and toxicokinetic. This review also provides insight into discussions on the key specialized secondary metabolism in P. cerasoides responsible for pharmacological/therapeutic action.